Discontinued — last reported Q4 '23

Business Segments · Service fees

CarelonRx Segment — Service fees

Elevance Health CarelonRx Segment — Service fees decreased by 50.0% to $2.00M in Q4 2023 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2020
Last reportedQ4 2023

How to read this metric

An increase suggests growth in high-margin service-based contracts and administrative business lines.

Detailed definition

This represents revenue earned by the CarelonRx segment for providing administrative, clinical, or management services r...

Peer comparison

Commonly reported as 'Service Revenue' or 'Administrative Fees' in healthcare services companies.

Metric ID: elv_segment_carelonrx_segment_service_fees

Historical Data

11 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$4.00M$2.00M
QoQ Change-50.0%
Range$0.00$4.00M

Frequently Asked Questions

What is Elevance Health's carelonrx segment — service fees?
Elevance Health (ELV) reported carelonrx segment — service fees of $2.00M in Q4 2023.
What does carelonrx segment — service fees mean?
Revenue earned from providing professional services rather than selling physical products.